DESITIN PHARMA A/S: Financial statements 2021
CVR: 19389006
Source: annual report 2021, Danish Business Authority
01/10/2020 – 30/09/2021
DESITIN PHARMA A/S (CVR 19389006) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 3,788,057 and a net result of DKK 353,005 compared with DKK 430,256 the year before. That is a decrease of 10.4% compared with the year before. Equity in the 2021 report amounted to DKK 6,442,096. The solvency ratio was 87.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,788,057
- Profit/Loss
- DKK 353,005
- Equity
- DKK 6,442,096
- Total Assets
- DKK 7,363,738
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 3.8M | 353K | 6.4M | 2 |
| 2020 | - | 4.2M | 430K | 6.1M | 3 |
| 2019 | - | 5.7M | 541K | 5.7M | 4 |
| 2018 | - | 6M | 1.5M | 5.1M | - |
| 2017 | - | 4.6M | 630K | 3.6M | - |
Official annual report
Find more companies like DESITIN PHARMA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout DESITIN PHARMA A/S
DESITIN PHARMA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Eli Lønne. The board consists of Philipp Andreas Bloching (chair), Eli Lønne and Oliver Christoph. The company is owned by Desitin Arzneimittel GmbH. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 3,230,179 and a net result of DKK 350,332 compared with DKK 288,733 the year before. Equity in the 2026 report amounted to DKK 7,394,472.